Mariner’s Cocrystal Pharma COCP Stock Holding History

Mariner’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,005	Closed	-$315K	–	1158
2021 Q3	$315K	Buy	25,005 +8,334	+50%	+$110K	﹤0.01%	932
2021 Q2	$250K	Buy	+16,671	New	+$253K	﹤0.01%	890

Other funds holding COCP

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Mariner's COCP Position: Q4 2021 in Review

Mariner sold out of Cocrystal Pharma (COCP) in Q4 2021, closing a stake of 25,005 shares — an estimated $315K sold.

Mariner first reported a position in COCP in Q2 2021 and held it in 2 quarters. The position peaked at $315K in Q3 2021. 35 funds tracked by Wall St. Rank hold COCP as of Q4 2021.

Mariner reported no remaining Cocrystal Pharma position as of Q4 2021 after selling out during the quarter.
Mariner sold 25,005 Cocrystal Pharma shares in Q4 2021, an estimated $315K.
Mariner first reported a position in Cocrystal Pharma in Q2 2021 and held it in 2 quarters.
Mariner's Cocrystal Pharma position peaked at $315K in Q3 2021.
35 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2021.

Based on Mariner's 13F filing for Q4 2021, filed 14 Feb 2022.